Myovant Sciences Announces Closing of $400 Million Loan Facility, Repayment of Debt, Board of Director Transitions, and Executive Promotions

NEXT STORY
Guardant Health to Present at the 38th Annual J.P. Morgan Healthcare Conference
PREV STORY
Advanced Image-guided Surgery Systems Industry Study, 2019: Technology Highlights and Market Outlook to 2024
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s Tecentriq in combination with Avastin shows encouraging results in Phase Ib study of people with unresectable hepatocellular carcinoma

author_avatar
NASDAQ Market News

U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density Lipoprotein (LDL)-Cholesterol

author_avatar
NASDAQ Market News

MPI – Resolution to implement merger

Hoersholm, Denmark, May 30, 2018 - today, an extraordinary general meeting Medical Prognosis Institute ...

author_avatar
NASDAQ Market News